Partially based on research at Duke University, Camras Vision is working on a treatment for refractory glaucoma.

Zapata, which remains in stealth mode, filed a security filing naming two of its directors as partners from MIT's the Engine and VC firm Pillar.

Johnson & Johnson has bought UW spinout C-Sats, which has created a platform to evaluate surgeons and helps them boost their skills.

UC's Office of the Chief Investment Officer has backed a new immuno-oncology startup that has licensed 17 assets from Pfizer.

Shibuya Corporation and Shinsei Bank joined existing investors in the liver disease therapy developer to buy $11.5m in convertible bonds.

Pfizer, which is providing 17 licensed drug assets to the immuno-oncology startup, will own a 25% stake once the series A round formally closes.

Medtronic spinout Inspire Medical Systems, the developer of a neurostimulation device for sleep apnea, has targeted $86.3m for its IPO.

Frazier Healthcare Partners has led a $9.3m funding round in Penn spinout Scout Bio.